PRLD Prelude Therapeutics Incorporated

36
-0.75  -2%
Previous Close 36.75
Open 36.1
52 Week Low 23.6931
52 Week High 50.19
Market Cap $1,573,321,716
Shares 43,703,381
Float 41,710,270
Enterprise Value $1,384,155,374
Volume 187,487
Av. Daily Volume 0
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
PRT543
Solid tumors
Phase 1
Phase 1
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
PRT543
Myelofibrosis
Phase 1
Phase 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.